Nanobiotix SA

NBTX · NYSE

$29.36+$0.17 (+0.58%)TodayMarket closed · Oct 23, 4:44 PM ET

Prev close $29.19

Latest news

NewsOct 22, 10:29 AM ETAvi Kapoor
Healthcare Services Posts Upbeat Q3 Earnings, Joins Pool, Spotify And Other Big Stocks Moving Higher On Thursday
NewsOct 21, 10:12 AM ETAvi Kapoor
Winnebago Industries Posts Upbeat Q4 Earnings, Joins SpaceX, Super Micro Computer And Other Big Stocks Moving Higher On Wednesday
Press releaseSep 24, 4:15 PM ETGlobe Newswire
NANOBIOTIX Provides First Half 2026 Operational and Financial Update
Press releaseSep 14, 2:00 AM ETGlobe Newswire
NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer
NewsSep 2, 10:26 AM ETAvi Kapoor
Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday
NewsAug 17, 1:06 PM ET
12 Health Care Stocks Moving In Monday's Intraday Session
Press releaseJun 2, 4:30 PM ETGlobe Newswire
Nanobiotix Provides First Quarter 2026 Operational and Financial Update
Press releaseMay 26, 4:44 PM ETGlobe Newswire
NANOBIOTIX Announces Closing of Global Offering
Press releaseMay 22, 4:15 PM ETGlobe Newswire
NANOBIOTIX Announces Full Exercise of Underwriters' Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million
Press releaseMay 20, 6:19 PM ETGlobe Newswire
Nanobiotix Announces Launch of Global Follow-On Offering
NewsMay 20, 5:05 PM ET
12 Health Care Stocks Moving In Wednesday's After-Market Session
NewsMay 19, 8:32 AM ETAvi Kapoor
XP Posts Downbeat Q1 Earnings, Joins Akamai Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
Press releaseMay 17, 10:15 AM ETGlobe Newswire
Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
Press releaseMay 4, 5:29 PM ETGlobe Newswire
Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study
NewsMar 31, 4:26 PM ET
Nanobiotix FY EPS $(0.58) Down From $1.56 YoY, Sales $37.943M Miss $165.540M Estimate
Press releaseMar 31, 4:15 PM ETGlobe Newswire
NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results
NewsMar 31, 7:11 AM ET
Earnings Scheduled For March 31, 2026
Press releaseMar 30, 2:30 AM ETGlobe Newswire
NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer
NewsMar 25, 1:02 PM ETVandana Singh
Cancer Drug Developer Nanobiotix Denies Any Active Takeover Process
NewsMar 13, 8:05 AM ET
12 Health Care Stocks Moving In Friday's Pre-Market Session
NewsNov 25, 8:01 AM ETAvi Kapoor
Semtech Posts Mixed Q3 Results, Joins Zhihu, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session
NewsOct 28, 1:06 PM ET
12 Health Care Stocks Moving In Tuesday's Intraday Session
NewsOct 28, 10:14 AM ETAvi Kapoor
Wayfair, Qorvo, Celestica, United Parcel Service, Regeneron Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday
NewsOct 20, 8:10 AM ETAvi Kapoor
Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session
Press releaseOct 7, 8:00 AM ETPRNewswire
Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms
NewsSep 18, 10:19 AM ETAvi Kapoor
Radian Group, Intel, Nanobiotix, CrowdStrike And Other Big Stocks Moving Higher On Thursday
NewsSep 18, 5:09 AM ETAvi Kapoor
Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket
NewsDec 10, 6:05 AM ETAvi Kapoor
Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket

Information on this page is provided for informational purposes only and is not a recommendation to buy, sell or hold any security. Investing involves risk, including possible loss of principal. Market data is delayed at least 15 minutes and is provided without warranty. Analyst ratings, price targets and company data come from third-party sources. Past performance does not guarantee future results.

Latest news

Healthcare Services Posts Upbeat Q3 Earnings, Joins Pool, Spotify And Other Big Stocks Moving Higher On Thursday

Winnebago Industries Posts Upbeat Q4 Earnings, Joins SpaceX, Super Micro Computer And Other Big Stocks Moving Higher On Wednesday

NANOBIOTIX Provides First Half 2026 Operational and Financial Update

NANOBIOTIX Announces Complete Full Cohort Phase 1 Results for JNJ-1900 (NBTXR3) in Inoperable, Recurrent Non-Small Cell Lung Cancer

Sirius XM, Dell, Ollie's Bargain Outlet And Other Big Stocks Moving Higher On Wednesday

12 Health Care Stocks Moving In Monday's Intraday Session

Nanobiotix Provides First Quarter 2026 Operational and Financial Update

NANOBIOTIX Announces Closing of Global Offering

NANOBIOTIX Announces Full Exercise of Underwriters' Over-Allotment Option, Bringing Gross Proceeds of Offering to Approximately $100 Million

Nanobiotix Announces Launch of Global Follow-On Offering

12 Health Care Stocks Moving In Wednesday's After-Market Session

XP Posts Downbeat Q1 Earnings, Joins Akamai Technologies And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Nanobiotix Announces Presentation of Part 1 Data From a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer

Nanobiotix Announces Protocol Amendment to Ongoing Global Phase 3 Head and Neck Cancer Study

Nanobiotix FY EPS $(0.58) Down From $1.56 YoY, Sales $37.943M Miss $165.540M Estimate

NANOBIOTIX Provides Business Update and Reports Full Year 2025 Financial Results

Earnings Scheduled For March 31, 2026

NANOBIOTIX Announces Presentation of First Data from a Randomized Phase 2 Clinical Trial Evaluating JNJ-1900 (NBTXR3) in Stage 3 Inoperable Lung Cancer

Cancer Drug Developer Nanobiotix Denies Any Active Takeover Process

12 Health Care Stocks Moving In Friday's Pre-Market Session

Semtech Posts Mixed Q3 Results, Joins Zhihu, Nvidia And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

12 Health Care Stocks Moving In Tuesday's Intraday Session

Wayfair, Qorvo, Celestica, United Parcel Service, Regeneron Pharmaceuticals And Other Big Stocks Moving Higher On Tuesday

Olema Pharmaceuticals, Exelixis, Genmab And Other Big Stocks Moving Lower In Monday's Pre-Market Session

Novel Cancer Platforms Converge as Clinical Data Reshapes Treatment Paradigms

Radian Group, Intel, Nanobiotix, CrowdStrike And Other Big Stocks Moving Higher On Thursday

Why Bullish Shares Are Trading Higher By 12%; Here Are 20 Stocks Moving Premarket

Why C3.ai Shares Are Trading Higher By Around 8%; Here Are 20 Stocks Moving Premarket